Items where Author is "Akbari, V."

Article

(2025) DCs pulsed with hypochlorous acid-treated tumor cell lysates present antigens efficiently and induce CD8+ T cell activation through cross-presentation. Research in Pharmaceutical Sciences. pp. 230-240. ISSN 1735-5362

(2024) Cloning and Optimization of Intracellular Expression of Human Interferon β-1a in Pichia pastoris GS115. Advanced Biomedical Research. p. 7. ISSN 2277-9175

(2024) Co-delivery of carboplatin and doxorubicin using ZIF-8 coated chitosan-poly(N-isopropyl acrylamide) nanoparticles through a dual pH/ thermo responsive strategy to breast cancer cells. International Journal of Biological Macromolecules. p. 18. ISSN 0141-8130

(2024) Integrated bioprocessing and genetic strategies to enhance soluble expression of anti-HER2 immunotoxin in E. Coli. Amb Express. p. 12. ISSN 2191-0855

(2024) More balance toward activating receptors and cytotoxic activity of NK cells ex vivo differentiated from human umbilical cord blood-derived CD34+stem cells in comparison with peripheral blood NK cells. Heliyon. p. 16.

(2024) Strong capacity of differentiated PD-L1 CAR-modified UCB-CD34+ cells and PD-L1 CAR-modified UCB-CD34+-derived NK cells in killing target cells and restoration of the anti-tumor function of PD-1-high exhausted T Cells. Stem Cell Research & Therapy. p. 17.

(2023) Anti HER-2 aptamer functionalized gold nanoparticles of dasatinib for targeted chemo-radiotherapy in breast cancer cells. Biomaterials Advances. p. 20.

(2023) Computational design of newly engineered DARPins as HER2 receptor inhibitors for breast cancer treatment. Research in Pharmaceutical Sciences. pp. 626-637. ISSN 1735-5362

(2023) Construction and periplasmic expression of a bispecific tandem scFv for dual targeting of immune checkpoints. Advanced Biomedical Research. p. 5. ISSN 2277-9175

(2023) Design and construction of scFv-PE35KDEL as a novel immunotoxin against human epidermal growth factor receptor 2 for cancer therapy. Biotechnology Letters. pp. 537-550. ISSN 0141-5492

(2023) Development of Solubilization and Refolding Buffers. Methods in molecular biology (Clifton, N.J.). pp. 155-164. ISSN 1940-6029 (Electronic) 1064-3745 (Linking)

(2023) Periplasmic Expression of a Novel Diabody for Co-Targeting Two Immune Checkpoints, PD-1 and CTLA-4. Journal of Isfahan Medical School. pp. 736-742. ISSN 10277595 (ISSN)

(2023) Preparation and Characterization of Trimethyl Chitosan /Hyaluronic Acid Composite Encapsulated with LL37 to Promote Wound Healing in an Animal Model. International Journal of Peptide Research and Therapeutics. p. 12. ISSN 1573-3149

(2023) Probiotic <i>Lactobacillus</i> and the potential risk of spreading antibiotic resistance: a systematic review. Research in Pharmaceutical Sciences. pp. 468-477. ISSN 1735-5362

(2022) Bioprocess optimization of interferon beta-1-a in Pichia pastoris and its improved inhibitory effect against hepatocellular carcinoma cells. BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES. ISSN 1984-8250 2175-9790 J9 - BRAZ J PHARM SCI

(2022) Bioprocess optimization of interferon β-1-a in <i>Pichia pastoris</i> and its improved inhibitory effect against hepatocellular carcinoma cells. Brazilian Journal of Pharmaceutical Sciences. p. 11. ISSN 1984-8250

(2022) Cancer vaccines as a targeted immunotherapy approach for breast cancer: an update of clinical evidence. EXPERT REVIEW OF VACCINES. pp. 337-353. ISSN 1476-0584 1744-8395 J9 - EXPERT REV VACCINES

(2022) Co-Expression of Chaperones for Improvement of Soluble Expression and Purification of An Anti-HER2 scFv in <i>Escherichia Coli</i>. Advanced Biomedical Research. p. 6. ISSN 2277-9175

(2022) Comparison of four methods of colon cancer cell lysates preparation for ex vivo maturation of dendritic cells. RESEARCH IN PHARMACEUTICAL SCIENCES. pp. 43-52. ISSN 1735-5362 1735-9414 J9 - RES PHARM SCI

(2022) Drug repositioning approach to target viral and host cells in terms of COVID-19 treatment: A review of in vivo experiments and clinical studies. Journal of Experimental and Clinical Medicine (Turkey). pp. 1255-1269. ISSN 13094483 (ISSN)

(2022) Efficacy and safety of ibrutinib in mantle cell lymphoma: A systematic review and meta-analysis. Daru. ISSN 1560-8115

(2022) Nisin induces apoptosis in cervical cancer cells via reactive oxygen species generation and mitochondrial membrane potential changes. BIOCHEMISTRY AND CELL BIOLOGY. pp. 136-141. ISSN 0829-8211 1208-6002 J9 - BIOCHEM CELL BIOL

(2022) Preparation and in vitro characterization of histidine trimethyl chitosan conjugated nanocomplex incorporated into injectable thermosensitive hydrogels for localized gene delivery. Biotechnol Appl Biochem. pp. 1047-1057. ISSN 0885-4513

(2022) Preparation, physicochemical, and retinal anti-angiogenic evaluation of poloxamer hydrogel containing dexamethasone/avastin-loaded chitosan-<i>N</i>-acetyl-L-cysteine nanoparticles. International Journal of Biological Macromolecules. pp. 1605-1618. ISSN 0141-8130

(2022) An injectable thermosensitive hydrogel/nanomicelles composite for local chemo-immunotherapy in mouse model of melanoma. JOURNAL OF BIOMATERIALS APPLICATIONS. pp. 551-562. ISSN 0885-3282 1530-8022 J9 - J BIOMATER APPL

(2021) Bioassay-guided fractionation and antimicrobial activities of Padina australis extracts. JUNDISHAPUR JOURNAL OF NATURAL PHARMACEUTICAL PRODUCTS. ISSN 17357780 (ISSN)

(2021) DFF40-iRGD, a novel chimeric protein with efficient cytotoxic and apoptotic effects against triple-negative breast cancer cells. BIOTECHNOLOGY LETTERS. pp. 1967-1976. ISSN 0141-5492 1573-6776 J9 - BIOTECHNOL LETT

(2021) Preparation and characterization of poly (lactic-co-glycolic acid) nanofibers containing simvastatin coated with hyaluronic acid for using in periodontal tissue engineering. Biotechnol Prog. e3195. ISSN 1520-6033

(2021) Production and Evaluation of In-vitro and In-vivo Effects of P28-IL24, a Promising Anti-breast Cancer Fusion Protein. INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS. pp. 2583-2594. ISSN 1573-3149 1573-3904 J9 - INT J PEPT RES THER

(2021) Risk of neurodegenerative disease due to tau phosphorylation changes and arsenic exposure via drinking water. Toxicol Res (Camb). pp. 325-333. ISSN 2045-452X (Print) 2045-452x

(2021) Survivin Promoter-Driven DFF40 Gene Expression Sensitizes Melanoma Cancer Cells to Chemotherapy. International Journal of Toxicology. pp. 380-387. ISSN 1091-5818

(2021) Sustained-release of erythropoietin using a novel injectable thermosensitive hydrogel: in vitro studies, biological activity, and efficacy in rats. Pharmaceutical Development and Technology. pp. 412-421. ISSN 1083-7450

(2016) Clinical applications of cell encapsulation technology in cell and drug delivery. Journal of Isfahan Medical School. pp. 259-269. ISSN 10277595 (ISSN)

(2016) Effects of probiotic supplementation in patients with type 2 diabetes: systematic review and meta-analysis. Nutrition Reviews. pp. 774-785. ISSN 0029-6643

(2016) Efficacy and safety of oral insulin compared to subcutaneous insulin: a systematic review and meta-analysis. Journal of Endocrinological Investigation. pp. 215-225. ISSN 1720-8386

(2016) Optimization of the expression of phaC2 encoding poly (3-hydroxyalkanoate) synthase from Pseudomonas aeruginosa PTCC1310 in Fad B deleted Escherichia coli. Advanced biomedical research. p. 50. ISSN 2277-9175 (Print) 2277-9175 (Linking)

(2015) Improved biological activity of a single chain antibody fragment against human epidermal growth factor receptor 2 (HER2) expressed in the periplasm of Escherichia coli. Protein Expression and Purification. pp. 66-74. ISSN 1046-5928

(2015) Optimization of a single-chain antibody fragment overexpression in Escherichia coli using response surface methodology. Research in Pharmaceutical Sciences. pp. 75-83. ISSN 1735-5362

(2015) Release Studies on Ciprofloxacin Loaded Non-ionic Surfactant Vesicles. Avicenna journal of medical biotechnology. pp. 69-75. ISSN 2008-2835 (Print) 2008-2835 (Linking)